Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,521-2,532 of 4,306
Drug study icon
CompletedNCT01281527

Paliperidone Palmitate Flexible Dosing in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Salzburg
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
France, United Kingdom, Switzerland, ...
Sponsor
Janssen-Cilag International NV
Condition
Schizophrenia
Drug study icon
CompletedNCT01154829

Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)

This summary needs review. Please check the official study record and contact the research team for details.

In Glostrup Municipality
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 45 Years
Countries
Denmark
Sponsor
University of Copenhagen
Condition
Schizophrenia
Drug study icon
CompletedNCT02339844

Pan European Collaboration on Antipsychotic Naïve Schizophrenia II

This summary needs review. Please check the official study record and contact the research team for details.

In Copenhagen
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 45 Years
Countries
Denmark
Sponsor
University of Copenhagen
Condition
Schizophrenia
Behavioral study icon
CompletedNCT00144027

Patient-Centered Medication Adherence Intervention for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In No. Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 70 Years
Countries
United States
Sponsor
US Department of Veterans Affairs
Condition
Schizophrenia
Drug study icon
CompletedNCT00230828

Patient-reported Outcomes in the Treatment of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 75 Years
Countries
Sponsor
Solvay Pharmaceuticals
Condition
Schizophrenia
Drug study icon
CompletedNCT01435928

PEARL Schizophrenia Maintenance

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Springdale
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 75 Years
Countries
United States, France, Italy, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01911429

Pediatric Schizophrenia Efficacy and Safety Study

This study is completed in the United States, in France, in the United Kingdom, .... It focuses on schizophrenia.

Multiple locations, including Dothan
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 13 Years to 17 Years
Countries
United States, France, United Kingdom, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.